Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4102077
Max Phase: Preclinical
Molecular Formula: C67H117N23O8S
Molecular Weight: 1404.89
Molecule Type: Small molecule
Associated Items:
ID: ALA4102077
Max Phase: Preclinical
Molecular Formula: C67H117N23O8S
Molecular Weight: 1404.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)NC(=O)N[C@H](CNC(=O)N[C@@H](CCCCN)CNC(=O)N[C@H](CNC(=O)N[C@H](CNC(=S)N[C@@H](CCCCN)CNC(=O)N[C@H](CNC(=O)N[C@@H](CCCCN)CNC(=O)N[C@H](CNC(N)=O)C(C)C)Cc1c[nH]c2ccccc12)C(C)C)Cc1c[nH]c2ccccc12)C(C)C
Standard InChI: InChI=1S/C67H117N23O8S/c1-41(2)56(38-74-59(71)91)88-64(96)77-34-48(20-14-17-27-69)83-60(92)78-36-50(29-45-31-72-54-24-11-9-22-52(45)54)85-62(94)76-35-49(21-15-18-28-70)87-67(99)81-40-58(43(5)6)89-65(97)79-37-51(30-46-32-73-55-25-12-10-23-53(46)55)86-61(93)75-33-47(19-13-16-26-68)84-63(95)80-39-57(42(3)4)90-66(98)82-44(7)8/h9-12,22-25,31-32,41-44,47-51,56-58,72-73H,13-21,26-30,33-40,68-70H2,1-8H3,(H3,71,74,91)(H2,75,86,93)(H2,76,85,94)(H2,77,88,96)(H2,78,83,92)(H2,79,89,97)(H2,80,84,95)(H2,81,87,99)(H2,82,90,98)/t47-,48-,49-,50-,51-,56+,57+,58+/m0/s1
Standard InChI Key: CTNGVRJBZXNDKB-HYCIEDERSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1404.89 | Molecular Weight (Monoisotopic): 1403.9176 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Antunes S, Corre JP, Mikaty G, Douat C, Goossens PL, Guichard G.. (2017) Effect of replacing main-chain ureas with thiourea and guanidinium surrogates on the bactericidal activity of membrane active oligourea foldamers., 25 (16): [PMID:28687228] [10.1016/j.bmc.2017.04.040] |
Source(1):